Valink is developing a series of novel therapeutics that are more effective at attacking tumours, while sparing healthy tissue.
Location: United States
Total raised: $11.8M
Investors 4
| Date | Name | Website |
| 07.12.2023 | Y Combinat... | ycombinato... |
| 01.07.2025 | Thomas McI... | tgm.com |
| - | Oxonian Ve... | oxonianven... |
| 01.12.2024 | p53 | p53.no |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.10.2025 | - | $11.8M | Redalpine ... |
Mentions in press and media 5
| Date | Title | Description |
| 15.09.2026 | LabKey Deploys Biologics LIMS at Valink Therapeutics for Company-Wide R&D Data Infrastructure | LabKey Biologics LIMS LabKey Valink Therapeutics Implementation spans molecular registry, sample management, assay data capture, and electronic lab notebooks, with Valink building automation on LabKey's API Valink is exactly the kind of cus... |
| 20.10.2025 | Valink Therapeutics Secures $11.8 Million to Advance Next-Generation Oncology | Valink Therapeutics secured $11.8 million in pre-A funding. This capital accelerates its next-generation oncology pipeline. The company focuses on innovative bispecific antibody-drug conjugates (bsADCs). Its proprietary V-gate technology en... |
| 20.10.2025 | Valink Therapeutics: $11.8 Million Pre-A Funding Secured To Advance Next-Generation Oncology Pipeline | Valink Therapeutics, a biotechnology company developing next-generation oncology therapeutics focused on bispecific antibody-drug conjugates (bsADCs) and complementary treatment modalities, announced the successful closing of an $11.8 milli... |
| 20.10.2025 | Valink Therapeutics Closes $11.8M Pre-A Financing Round | Valink Therapeutics, Inc., a Cambridge, MA-based biotechnology company developing next-generation oncology therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities for improved patient outcomes,... |
| - | Valink Therapeutics | “Valink is developing a series of novel therapeutics that are more effective at attacking tumours, while sparing healthy tissue.” |